摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-[1-Ethyl-4-methoxy-3-(3-methoxy-phenyl)-1H-indol-6-ylmethyl]-pyrimidine-2,4-diamine | 372100-64-6

中文名称
——
中文别名
——
英文名称
5-[1-Ethyl-4-methoxy-3-(3-methoxy-phenyl)-1H-indol-6-ylmethyl]-pyrimidine-2,4-diamine
英文别名
5-[[1-Ethyl-4-methoxy-3-(3-methoxyphenyl)indol-6-yl]methyl]pyrimidine-2,4-diamine
5-[1-Ethyl-4-methoxy-3-(3-methoxy-phenyl)-1H-indol-6-ylmethyl]-pyrimidine-2,4-diamine化学式
CAS
372100-64-6
化学式
C23H25N5O2
mdl
——
分子量
403.484
InChiKey
MCNHFDIFHZPUQF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    30
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    101
  • 氢给体数:
    2
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    6-(2,4-diamino-pyrimidin-5-ylmethyl)-1-ethyl-3-(3-methoxy-phenyl)-1H-indol-4-ol碘甲烷 以35 mg (34%)的产率得到5-[1-Ethyl-4-methoxy-3-(3-methoxy-phenyl)-1H-indol-6-ylmethyl]-pyrimidine-2,4-diamine
    参考文献:
    名称:
    Pyrimidinyl methyl indole derivatives with antibacterial activity
    摘要:
    这项发明涉及通式(I)的吲哚衍生物,其中R1是烷基,烯基,炔基,环烷基,环烷基烷基,烷基磺酰基,环烷基磺酰基,环烷基烷基磺酰基,二烷基磺酰胺基,N-环烷基-N-烷基磺酰胺基,杂环烷基烷基或苯基烷基;R2是氢,卤素,烷基,醇酰基,苯基,苯基烷基或杂环烷基烷基;R3是氢,烷基;以及R4是烷基,烯基,炔基,环烷基,环烷基烷基,烷基磺酰基,环烷基磺酰基,环烷基烷基磺酰基,二烷基磺酰胺基,N-环烷基-N-烷基磺酰胺基,杂环烷基烷基或苯基烷基;以及这些化合物的药学上可接受的酸盐,它们作为治疗活性物质的用途;基于这些物质的药物,可选地与磺胺类药物结合,以及它们的生产;这些物质作为药物以及用于生产抗菌活性药物的用途;以及通式(I)化合物及其药学上可接受的酸盐的制造,以及用于其制造的中间体。
    公开号:
    US20030119857A1
点击查看最新优质反应信息

文献信息

  • PYRIMIDINYL METHYL INDOLE DERIVATIVES WITH ANTIBACTERIAL ACTIVITY
    申请人:Basilea Pharmaceutica AG
    公开号:EP1280796A1
    公开(公告)日:2003-02-05
  • US6703397B2
    申请人:——
    公开号:US6703397B2
    公开(公告)日:2004-03-09
  • [EN] PYRIMIDINYL METHYL INDOLE DERIVATIVES WITH ANTIBACTERIAL ACTIVITY<br/>[FR] DERIVES DE PYRIMIDINYL METHYL INDOLE A ACTIVITE ANTIBACTERIENNE
    申请人:HOFFMANN LA ROCHE
    公开号:WO2001083474A1
    公开(公告)日:2001-11-08
    This invention relates to indole derivatives of the general formula (I) wherein R1 is alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, alkylsulfonyl, cycloalkylsulfonyl, cycloalkylalkylsulfonyl, dialkylsulfamoyl, N-cycloalkyl-N-alkylsulfamoyl, heterocyclylalkyl or phenylalkyl; R2 is hydrogen, halogen, alkyl, alkanoyl, phenyl, phenylalkyl or heterocyclylalkyl; R3 is hydrogen, alkyl; and R4 is alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, alkylsulfonyl, cycloalkylsulfonyl, cycloalkylalkylsulfonyl, dialkylsulfamoyl, N-cycloalkyl-N-alkylsulfamoyl, heterocyclylalkyl, or phenylalkyl; and pharmaceutically acceptable acid addition salts of these compounds, there use as therapeutically active substances; medicaments based on these substances, optionally in combination with sulphonamides, and their production; the use of these substances as medicaments and for the production of antibacterially-active medicaments; as well as the manufacture of the compounds of formula (I) and their pharmaceutically acceptable acid addition salts and intermediates for their manufacture.
  • Pyrimidinyl methyl indole derivatives with antibacterial activity
    申请人:——
    公开号:US20030119857A1
    公开(公告)日:2003-06-26
    This invention relates to indole derivatives of the general formula (I) wherein R 1 is alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, alkylsulfonyl, cycloalkylsulfonyl, cycloalkylalkylsulfonyl, dialkylsulfamoyl, N-cycloalkyl-N-alkylsulfamoyl, heterocyclylalkyl or phenylalkyl; R 2 is hydrogen, halogen, alkyl, alkanoyl, phenyl, phenylalkyl or heterocyclylalkyl; R 3 is hydrogen, alkyl; and R 4 is alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, alkylsulfonyl, cycloalkylsulfonyl, cycloalkylalkylsulfonyl, dialkylsulfamoyl, N-cycloalkyl-N-alkylsulfamoyl, heterocyclylalkyl, or phenylalkyl; and pharmaceutically acceptable acid addition salts of these compounds, there use as therapeutically active substances; medicaments based on these substances, optionally in combination with sulphonamides, and their production; the use of these substances as medicaments and for the production of antibacterially-active medicaments; as well as the manufacture of the compounds of formula (I) and their pharmaceutically acceptable acid addition salts and intermediates for their manufacture.
    这项发明涉及通式(I)的吲哚衍生物,其中R1是烷基,烯基,炔基,环烷基,环烷基烷基,烷基磺酰基,环烷基磺酰基,环烷基烷基磺酰基,二烷基磺酰胺基,N-环烷基-N-烷基磺酰胺基,杂环烷基烷基或苯基烷基;R2是氢,卤素,烷基,醇酰基,苯基,苯基烷基或杂环烷基烷基;R3是氢,烷基;以及R4是烷基,烯基,炔基,环烷基,环烷基烷基,烷基磺酰基,环烷基磺酰基,环烷基烷基磺酰基,二烷基磺酰胺基,N-环烷基-N-烷基磺酰胺基,杂环烷基烷基或苯基烷基;以及这些化合物的药学上可接受的酸盐,它们作为治疗活性物质的用途;基于这些物质的药物,可选地与磺胺类药物结合,以及它们的生产;这些物质作为药物以及用于生产抗菌活性药物的用途;以及通式(I)化合物及其药学上可接受的酸盐的制造,以及用于其制造的中间体。
查看更多